UniProt ID | CNTP2_HUMAN | |
---|---|---|
UniProt AC | Q9UHC6 | |
Protein Name | Contactin-associated protein-like 2 | |
Gene Name | CNTNAP2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1331 | |
Subcellular Localization |
Membrane Single-pass type I membrane protein . Cell projection, axon . Cell junction, paranodal septate junction . Expressed in the juxtaparadonal region. |
|
Protein Description | Required, with CNTNAP1, for radial and longitudinal organization of myelinated axons. Plays a role in the formation of functional distinct domains critical for saltatory conduction of nerve impulses in myelinated nerve fibers. Demarcates the juxtaparanodal region of the axo-glial junction.. | |
Protein Sequence | MQAAPRAGCGAALLLWIVSSCLCRAWTAPSTSQKCDEPLVSGLPHVAFSSSSSISGSYSPGYAKINKRGGAGGWSPSDSDHYQWLQVDFGNRKQISAIATQGRYSSSDWVTQYRMLYSDTGRNWKPYHQDGNIWAFPGNINSDGVVRHELQHPIIARYVRIVPLDWNGEGRIGLRIEVYGCSYWADVINFDGHVVLPYRFRNKKMKTLKDVIALNFKTSESEGVILHGEGQQGDYITLELKKAKLVLSLNLGSNQLGPIYGHTSVMTGSLLDDHHWHSVVIERQGRSINLTLDRSMQHFRTNGEFDYLDLDYEITFGGIPFSGKPSSSSRKNFKGCMESINYNGVNITDLARRKKLEPSNVGNLSFSCVEPYTVPVFFNATSYLEVPGRLNQDLFSVSFQFRTWNPNGLLVFSHFADNLGNVEIDLTESKVGVHINITQTKMSQIDISSGSGLNDGQWHEVRFLAKENFAILTIDGDEASAVRTNSPLQVKTGEKYFFGGFLNQMNNSSHSVLQPSFQGCMQLIQVDDQLVNLYEVAQRKPGSFANVSIDMCAIIDRCVPNHCEHGGKCSQTWDSFKCTCDETGYSGATCHNSIYEPSCEAYKHLGQTSNYYWIDPDGSGPLGPLKVYCNMTEDKVWTIVSHDLQMQTPVVGYNPEKYSVTQLVYSASMDQISAITDSAEYCEQYVSYFCKMSRLLNTPDGSPYTWWVGKANEKHYYWGGSGPGIQKCACGIERNCTDPKYYCNCDADYKQWRKDAGFLSYKDHLPVSQVVVGDTDRQGSEAKLSVGPLRCQGDRNYWNAASFPNPSSYLHFSTFQGETSADISFYFKTLTPWGVFLENMGKEDFIKLELKSATEVSFSFDVGNGPVEIVVRSPTPLNDDQWHRVTAERNVKQASLQVDRLPQQIRKAPTEGHTRLELYSQLFVGGAGGQQGFLGCIRSLRMNGVTLDLEERAKVTSGFISGCSGHCTSYGTNCENGGKCLERYHGYSCDCSNTAYDGTFCNKDVGAFFEEGMWLRYNFQAPATNARDSSSRVDNAPDQQNSHPDLAQEEIRFSFSTTKAPCILLYISSFTTDFLAVLVKPTGSLQIRYNLGGTREPYNIDVDHRNMANGQPHSVNITRHEKTIFLKLDHYPSVSYHLPSSSDTLFNSPKSLFLGKVIETGKIDQEIHKYNTPGFTGCLSRVQFNQIAPLKAALRQTNASAHVHIQGELVESNCGASPLTLSPMSSATDPWHLDHLDSASADFPYNPGQGQAIRNGVNRNSAIIGGVIAVVIFTILCTLVFLIRYMFRHKGTYHTNEAKGAESAESADAAIMNNDPNFTETIDESKKEWLI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
100 | Phosphorylation | KQISAIATQGRYSSS HEEEEEEECCCCCCC | 25.99 | - | |
183 | Phosphorylation | IEVYGCSYWADVINF EEEEEECEEEEEEEE | 14.53 | - | |
287 | Phosphorylation | VIERQGRSINLTLDR EEEECCCEEEEEEEH | 23.74 | 23403867 | |
289 | N-linked_Glycosylation | ERQGRSINLTLDRSM EECCCEEEEEEEHHH | 28.37 | UniProtKB CARBOHYD | |
346 | N-linked_Glycosylation | SINYNGVNITDLARR HHCCCCCCHHHHHHH | 32.61 | UniProtKB CARBOHYD | |
348 | Phosphorylation | NYNGVNITDLARRKK CCCCCCHHHHHHHCC | 21.54 | - | |
363 | N-linked_Glycosylation | LEPSNVGNLSFSCVE CCCCCCCCCEEEECC | 28.38 | UniProtKB CARBOHYD | |
379 | N-linked_Glycosylation | YTVPVFFNATSYLEV CEEEEEEECCCCEEC | 30.74 | UniProtKB CARBOHYD | |
429 | Phosphorylation | VEIDLTESKVGVHIN EEEECCCCEEEEEEE | 27.66 | - | |
436 | N-linked_Glycosylation | SKVGVHINITQTKMS CEEEEEEEECCCCCC | 19.17 | UniProtKB CARBOHYD | |
506 | N-linked_Glycosylation | GGFLNQMNNSSHSVL HHHHHHCCCCCCCCC | 35.15 | UniProtKB CARBOHYD | |
507 | N-linked_Glycosylation | GFLNQMNNSSHSVLQ HHHHHCCCCCCCCCC | 39.28 | UniProtKB CARBOHYD | |
546 | N-linked_Glycosylation | RKPGSFANVSIDMCA CCCCCCCCCEEEEEH | 26.51 | UniProtKB CARBOHYD | |
579 | Phosphorylation | TWDSFKCTCDETGYS CCCCEEEEECCCCCC | 24.47 | 19690332 | |
583 | Phosphorylation | FKCTCDETGYSGATC EEEEECCCCCCCCCC | 28.33 | 19690332 | |
589 | Phosphorylation | ETGYSGATCHNSIYE CCCCCCCCCCCCCCC | 20.16 | 19690332 | |
595 | Phosphorylation | ATCHNSIYEPSCEAY CCCCCCCCCCCHHHH | 22.93 | 19690332 | |
630 | N-linked_Glycosylation | GPLKVYCNMTEDKVW CCEEEEEECCCCCEE | 23.79 | UniProtKB CARBOHYD | |
638 | Phosphorylation | MTEDKVWTIVSHDLQ CCCCCEEEEEECCCC | 17.94 | - | |
641 | Phosphorylation | DKVWTIVSHDLQMQT CCEEEEEECCCCCCC | 13.87 | - | |
658 | Phosphorylation | VGYNPEKYSVTQLVY CCCCHHHCCEEEEEE | 13.50 | 25907765 | |
659 | Phosphorylation | GYNPEKYSVTQLVYS CCCHHHCCEEEEEEE | 29.74 | 25907765 | |
661 | Phosphorylation | NPEKYSVTQLVYSAS CHHHCCEEEEEEECC | 15.39 | 25907765 | |
665 | Phosphorylation | YSVTQLVYSASMDQI CCEEEEEEECCHHHH | 13.70 | 25907765 | |
666 | Phosphorylation | SVTQLVYSASMDQIS CEEEEEEECCHHHHH | 13.34 | 25907765 | |
668 | Phosphorylation | TQLVYSASMDQISAI EEEEEECCHHHHHHH | 19.56 | 25907765 | |
673 | Phosphorylation | SASMDQISAITDSAE ECCHHHHHHHHCCHH | 14.16 | 25907765 | |
676 | Phosphorylation | MDQISAITDSAEYCE HHHHHHHHCCHHHHH | 24.50 | 25907765 | |
678 | Phosphorylation | QISAITDSAEYCEQY HHHHHHCCHHHHHHH | 17.85 | 25907765 | |
681 | Phosphorylation | AITDSAEYCEQYVSY HHHCCHHHHHHHHHH | 10.87 | 25907765 | |
685 | Phosphorylation | SAEYCEQYVSYFCKM CHHHHHHHHHHHHHH | 2.97 | 25907765 | |
687 | Phosphorylation | EYCEQYVSYFCKMSR HHHHHHHHHHHHHHH | 13.93 | 25907765 | |
688 | Phosphorylation | YCEQYVSYFCKMSRL HHHHHHHHHHHHHHH | 11.71 | 25907765 | |
735 | N-linked_Glycosylation | CACGIERNCTDPKYY CCCCCCCCCCCCCCC | 21.91 | UniProtKB CARBOHYD | |
760 | Phosphorylation | RKDAGFLSYKDHLPV HHHCCCCCCCCCCCH | 28.07 | 24114839 | |
852 | Phosphorylation | FIKLELKSATEVSFS EEEEEECCCCEEEEE | 53.71 | - | |
854 | Phosphorylation | KLELKSATEVSFSFD EEEECCCCEEEEEEE | 43.97 | - | |
857 | Phosphorylation | LKSATEVSFSFDVGN ECCCCEEEEEEECCC | 14.67 | - | |
859 | Phosphorylation | SATEVSFSFDVGNGP CCCEEEEEEECCCCC | 17.03 | - | |
1017 | Phosphorylation | EEGMWLRYNFQAPAT CCCCEEEEEEECCCC | 20.40 | 29978859 | |
1071 | Phosphorylation | LLYISSFTTDFLAVL EEEEECCCCCEEHHH | 27.66 | - | |
1072 | Phosphorylation | LYISSFTTDFLAVLV EEEECCCCCEEHHHC | 23.81 | - | |
1116 | N-linked_Glycosylation | NGQPHSVNITRHEKT CCCCCEEECEECCEE | 32.69 | UniProtKB CARBOHYD | |
1198 | N-linked_Glycosylation | KAALRQTNASAHVHI HHHHHHCCCCCEEEE | 24.45 | UniProtKB CARBOHYD | |
1285 | Phosphorylation | TLVFLIRYMFRHKGT HHHHHHHHHHHHCCC | 8.13 | 28270605 | |
1292 | Phosphorylation | YMFRHKGTYHTNEAK HHHHHCCCCCCCCCC | 19.55 | 28270605 | |
1293 | Phosphorylation | MFRHKGTYHTNEAKG HHHHCCCCCCCCCCC | 18.47 | 28270605 | |
1295 | Phosphorylation | RHKGTYHTNEAKGAE HHCCCCCCCCCCCCC | 25.08 | 28270605 | |
1303 | Phosphorylation | NEAKGAESAESADAA CCCCCCCCHHHHCHH | 36.48 | 20363803 | |
1306 | Phosphorylation | KGAESAESADAAIMN CCCCCHHHHCHHHHC | 31.03 | 19413330 | |
1319 | Phosphorylation | MNNDPNFTETIDESK HCCCCCCCCCCCHHH | 38.57 | 25002506 | |
1321 | Phosphorylation | NDPNFTETIDESKKE CCCCCCCCCCHHHHH | 30.58 | 25002506 | |
1325 | Phosphorylation | FTETIDESKKEWLI- CCCCCCHHHHHHCC- | 45.33 | 25002506 | |
1326 | Ubiquitination | TETIDESKKEWLI-- CCCCCHHHHHHCC-- | 53.30 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CNTP2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CNTP2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CNTP2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CNTN2_HUMAN | CNTN2 | physical | 12975355 | |
E41L3_HUMAN | EPB41L3 | physical | 12542678 | |
CSKP_HUMAN | CASK | physical | 12093160 | |
CTR9_HUMAN | CTR9 | physical | 12421765 | |
ZMIZ1_HUMAN | ZMIZ1 | physical | 12421765 | |
MACF1_HUMAN | MACF1 | physical | 12421765 | |
MEOX2_HUMAN | MEOX2 | physical | 24722188 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00756 | Pitt-Hopkins syndrome, including: Pitt-Hopkins syndrome; Pitt-Hopkins-like syndrome | |||||
OMIM Disease | ||||||
610042 | Cortical dysplasia-focal epilepsy syndrome (CDFES) | |||||
612100 | Autism 15 (AUTS15) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1303 AND SER-1306, ANDMASS SPECTROMETRY. |